Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program-Reference-Cited by-同舟云学术

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

Published:2011-09-13 Issue:1 Volume:9 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Garland Suzanne M, ,Brotherton Julia ML,Condon John R,McIntyre Peter B,Stevens Matthew P,Smith David W,Tabrizi Sepehr N

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1741-7015-9-104.pdf

Reference43 articles.

1. Australian Institute of Health and Welfare 2010: Cervical screening in Australia 2007-2008: data report. Cancer series no 54 Cat no CAN 50. 2010, Canberra: AIHW

2. De Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Valejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Ijazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GAH, Lombardi LE, Banjo A, on behalf of the Retrospective International Survey and HPV Time Trends Study Group, et al: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010, 11: 1048-56. 10.1016/S1470-2045(10)70230-8.

3. Stevens MP, Tabrizi SN, Quinn MA, Garland SM: Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial or cervical cancer in Melbourne, Australia. Int J of Gynecol Cancer. 2006, 16: 1017-24. 10.1111/j.1525-1438.2006.00453.x.

4. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow S-N, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamram U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WAJ, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, for the HPV PATRICIA Study Group: Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009, 374: 301-14. 10.1016/S0140-6736(09)61248-4.

5. Garland SM, Hernandez AM, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007, 356: 1928-43. 10.1056/NEJMoa061760.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between smoking and cervical human papillomavirus infection among women from indigenous communities in western Botswana;PLOS ONE;2024-06-07

2. Addressing the burden of cervical cancer for Indigenous women in Latin America and the Caribbean: a call for action;Frontiers in Public Health;2024-05-14

3. Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening;British Journal of Cancer;2024-04-13

4. High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study;PLOS ONE;2024-02-05

5. Roles of adipose-derived stem cells and derived exosomes in therapeutic applications to testicular injury caused by cisplatin;PLOS ONE;2024-02-05